Cost Plus Drug Company Stock
Mark Cuban Cost Plus Drug Company (MCCPDC), also known as Cost Plus Drugs, is a direct-to-consumer platform specializing in affordable prescription medications. Its transparent pricing model includes a cost-plus 15% markup and flat fees for pharmacy services and shipping, disrupting the generic pharmaceutical market and aiming to make healthcare more accessible.
Founded: 2016
For more Cost Plus Drug Company stock information, or to buy or sell private shares, sign up for a MicroVentures account.
Management Team
| Mark Cuban Co-Founder |
| Alexander Oshmyansky Ph.D Co-Founder & Chief Executive Officer |
| Erin Albert Chief Privacy Officer & Vice President, Pharmacy Relations |
